Return to program book search
Epstein-Barr Virus (EBV) and Its Role in Cutaneous Disease
Friday, March 21
7:15 AM - 8:45 AM
Emily Keimig, MD, MS, FAAD
Following this course, the attendee should be able to:
- 1. Discuss the Epstein-Barr Virus (EBV) and the unique properties that promote its latency within the host immune system.
- 2. Summarize the spectrum of EBV-related cutaneous diseases and their various clinical presentations.
- 3. Recognize those patients at risk for the development of EBV-related cutaneous disease and discuss treatment challenges.
Epstein-Barr Virus (EBV) is a very common viral pathogen. It has been estimated that upwards of 50% of people are exposed by mid-childhood. Individuals with underlying immunodeficiency or iatrogenic immunosuppression are at increased risk for viral reactivation and the development of a multitude of potentially life threatening conditions. In this session, we will discuss the unique properties of the virus that permit latency, the spectrum of EBV-related cutaneous conditions, treatment options, and the challenges that EBV infection presents.